The National Institute on Drug Abuse (NIDA) is offering the Avant-Garde Award Program to support individual scientists of exceptional creativity. This NIDA grant is for proposing high-impact research that will open new areas of HIV/AIDS inquiry relevant to substance use disorder, ultimately leading to novel avenues for prevention and treatment among drug abusers. The program seeks highly innovative approaches and ideas that are substantially different from existing work, possessing the potential to be transformative. It supports creative, basic research that may lead to improved preventive interventions or therapies, new strategies to prevent disease transmission, novel approaches to improve disease outcomes, and efforts to eradicate HIV or enhance the lives of those living with HIV.
Opportunity ID: 327416
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-221 |
| Funding Opportunity Title: | NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 01, 2020 |
| Last Updated Date: | Jun 01, 2020 |
| Original Closing Date for Applications: | Aug 15, 2022 |
| Current Closing Date for Applications: | Aug 15, 2022 |
| Archive Date: | Sep 20, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $700,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education City or township governments Small businesses State governments Public housing authorities/Indian housing authorities County governments Special district governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. The proposed research should reflect approaches and ideas that are substantially different from those already being pursued by the investigator or others and should support the NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html. The NIDA Avant-Garde award supports innovative, basic research that may lead to improved preventive interventions or therapies; creative, new strategies to prevent disease transmission; novel approaches to improve disease outcomes; and creative approaches to eradicating HIV or improving the lives of those living with HIV. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-221.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 327416 Full Announcement-PAR-20-221 -> PAR-20-221-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00261987 | Jul 13, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269548 | Oct 27, 2021 | Aug 15, 2022 | View |
Package 1
Mandatory forms
327416 RR_SF424_2_0-2.0.pdf
327416 PHS398_CoverPageSupplement_5_0-5.0.pdf
327416 RR_OtherProjectInfo_1_4-1.4.pdf
327416 PerformanceSite_2_0-2.0.pdf
327416 RR_KeyPersonExpanded_2_0-2.0.pdf
327416 PHS398_ResearchPlan_4_0-4.0.pdf
327416 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
327416 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
327416 RR_SF424_5_0-5.0.pdf
327416 PerformanceSite_4_0-4.0.pdf
327416 RR_OtherProjectInfo_1_4-1.4.pdf
327416 RR_KeyPersonExpanded_4_0-4.0.pdf
327416 PHS398_CoverPageSupplement_5_0-5.0.pdf
327416 PHS398_ResearchPlan_4_0-4.0.pdf
327416 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
327416 PHS_AssignmentRequestForm_3_0-3.0.pdf
327416 RR_Budget10_3_0-3.0.pdf
327416 RR_SubawardBudget10_30_3_0-3.0.pdf
327416 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
